Patients undergoing atrial fibrillation (AFib) ablation who were not properly anticoagulated and did not undergo preprocedural transesophageal echocardiogram (TEE) were significantly more likely to ...

Christopher M. Kramer, MD, FACC, received his medical degree from the University of California, San Francisco School of Medicine, and completed his residency and chief residency in internal medicine, ...

Congratulations new Fellows and Associates! The College is proud to welcome you and stand with you during this milestone in your career. With your achievement, you have distinguished yourself as a ...

Compared with oral anticoagulant (OAC)-experienced patients, OAC-naïve patients received the same benefit in decreased bleeding risk with asundexian vs. apixaban but they were also less likely to ...

Explore the different ways the ACC is helping to improve clinician well-being, whether it's providing clinician education, encouraging conversations that matter, reducing unnecessary administrative ...

More patients who received the Watchman 2.5 device compared with the Amulet occluder device for left atrial appendage occlusion experienced high-risk device-related thrombi (DRTs), according to a ...

Click the year or decade below to view its content. Prague's Otto Klein, unaware of Forssmann's research performs 11 right heart catheterizations in patients, and records cardiac output measurements, ...

Tiny fragments of plastic have become ubiquitous in our environment and our bodies. Higher exposure to these microplastics, which can be inadvertently consumed or inhaled, is associated with a ...

Transcatheter tricuspid valve replacement (TTVR) may be a "feasible and effective approach" for treating high-risk patients with severe tricuspid regurgitation (TR) who have limited therapeutic ...

Completing (or Continuing) Your Training? Let's Stay in Touch! During and just after your training, the right support is critical. Ensure we're providing you with support tailored to your needs. If ...

Every week, ACC will continue to post new ACCEL content on the ACCEL Lite podcast.

An early one-time simultaneous measurement of LDL-C, high-sensitivity C-reactive protein (hsCRP) and lipoprotein(a) (Lp[a]) can independently predict long-term cardiovascular risk, according to a ...